Mobile healthcare solutions provider AirStrip acquired the assets of Sense4Baby, which makes a wireless fetal/maternal monitoring system to perform non-stress testing (NST) for high-risk pregnancies, and licensed the associated technology from the Gary and Mary West Health Institute. Terms of the deal were not disclosed.
Sense4Baby received FDA’ 510(k) clearance and European Commission’s CE mark to commercialize its medical device in clinical settings. The acquisition by AirStrip will initially allow women to undergo non-stress testing to monitor fetal and maternal heart rate and contraction patterns using non-invasive sensors at physicians’ offices, clinics and ambulances. Going forward, AirStrip plans to seek FDA clearance for home-based monitoring.
The patient data from the Sense4Baby system will be mobilized using AirStrip ONE, which delivers vendor- and data source-agnostic information from multiple sources and care settings to support multiple caregivers and mobile device form factors.
The Sense4Baby technology platform was originally researched at the West Health Institute, which licensed the technology to Sense4Baby. The company received an investment from the Gary and Mary West Health Investment Fund and was the first resident of the West Health Incubator.